These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 11118301)
21. Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Wu CC; Ko FN; Teng CM Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290 [TBL] [Abstract][Full Text] [Related]
22. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries. Miller MR; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ; Megson IL Eur J Pharmacol; 2000 Nov; 408(3):335-43. PubMed ID: 11090652 [TBL] [Abstract][Full Text] [Related]
23. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation. Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184 [TBL] [Abstract][Full Text] [Related]
24. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production. Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932 [TBL] [Abstract][Full Text] [Related]
25. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure. Kotikoski H; Kankuri E; Vapaatalo H Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation. Severina IS; Belushkina NN; Grigoryev NB Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264 [TBL] [Abstract][Full Text] [Related]
27. NO-donors, part 9 : diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates. Abuo-Rahma Gel D; Horstmann A; Radwan MF; El-Emam A; Glusa E; Lehmann J Eur J Med Chem; 2005 Mar; 40(3):281-7. PubMed ID: 15725497 [TBL] [Abstract][Full Text] [Related]
28. Nitric oxide regulates steroid synthesis by bovine antral granulosa cells in a chemically defined medium. Faes MR; Caldas-Bussiere MC; Viana KS; Dias BL; Costa FR; Escocard RM Anim Reprod Sci; 2009 Feb; 110(3-4):222-36. PubMed ID: 18372125 [TBL] [Abstract][Full Text] [Related]
29. Copper chelation-induced reduction of the biological activity of S-nitrosothiols. Gordge MP; Meyer DJ; Hothersall J; Neild GH; Payne NN; Noronha-Dutra A Br J Pharmacol; 1995 Mar; 114(5):1083-9. PubMed ID: 7780643 [TBL] [Abstract][Full Text] [Related]
30. Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent. Young DV; Serebryanik D; Janero DR; Tam SW Mol Cell Biol Res Commun; 2000 Jul; 4(1):32-6. PubMed ID: 11152625 [TBL] [Abstract][Full Text] [Related]
31. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets. Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647 [TBL] [Abstract][Full Text] [Related]
32. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Wong D; Dorovini-Zis K; Vincent SR Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883 [TBL] [Abstract][Full Text] [Related]
33. Effects of manipulating the nitric oxide/cyclic GMP pathway on bovine oocyte meiotic resumption in vitro. Bilodeau-Goeseels S Theriogenology; 2007 Sep; 68(5):693-701. PubMed ID: 17604095 [TBL] [Abstract][Full Text] [Related]
34. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation. Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116 [TBL] [Abstract][Full Text] [Related]
35. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes]. Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets. Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997 [TBL] [Abstract][Full Text] [Related]
38. Cardiac mitochondrial cGMP stimulates cytochrome c release. Seya K; Motomura S; Furukawa K Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461 [TBL] [Abstract][Full Text] [Related]
39. Sodium nitroprusside augments human lung fibroblast collagen gel contraction independently of NO-cGMP pathway. Liu XD; Skold CM; Umino T; Spurzem JR; Romberger DJ; Rennard SI Am J Physiol Lung Cell Mol Physiol; 2000 May; 278(5):L1032-8. PubMed ID: 10781435 [TBL] [Abstract][Full Text] [Related]
40. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries. Persson AA; Gunnarsson P; Lindström E; Grenegård M Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]